Funded Tech Companies
NeoPhore
Wondering who provided funding to NeoPhore? Bristol Myers Squibb, Astellas Venture Capital and Neva SGR joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
NeoPhore
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3rd Floor, 1 Ashley Road, Altrincham
Cheshire, WA14 2DT
UK
Cheshire, WA14 2DT
UK
Phone
Website
Email Address
Company Background Information
Overview
Our approach targets the dynamics of cancer neoantigen evolution through the discovery and design of effective, well-tolerated medicines that will become a key part of the next-generation of cancer immunotherapies. Our compounds target components of the MMR pathway that have been validated in both clinical and preclinical studies. These components are known to modulate neoantigen creation and diversity across numerous cancers.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/22/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Baker
Chief Financial Officer
Stephen Over
Chief Scientific Officer
Martin Drysdale
Company Investors
- Bristol Myers Squibb
- Astellas Venture Capital
- Neva SGR
- 3B Future Health Fund
- 2Invest
- Claris Ventures
- LIFTT
- CRT Pioneer Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs